ALPHA1-ANTITRYPSIN DEFICIENCY

Clinical trials for ALPHA1-ANTITRYPSIN DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new ALPHA1-ANTITRYPSIN DEFICIENCY trials appear

Sign up with your email to follow new studies for ALPHA1-ANTITRYPSIN DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Weekly shot tested for rare lung disease

Disease control Completed

This study tested the safety of two different doses of a weekly injection for people with Alpha-1 Antitrypsin Deficiency, a genetic condition that can cause lung disease. Seventeen adults with moderate lung impairment received the injections under the skin for eight weeks. The ma…

Matched conditions: ALPHA1-ANTITRYPSIN DEFICIENCY

Phase: PHASE1, PHASE2 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

ALPHA1-ANTITRYPSIN DEFICIENCY

Get alerted when new ALPHA1-ANTITRYPSIN DEFICIENCY trials appear

Weekly shot tested for rare lung disease